Xu S - Search Results

1

Tree-based data mining for safety assessment of first COVID-19 booster doses in the Vaccine Safety Datalink.

Katherine Yih W, Daley MF, Duffy J, Fireman B, McClure D, Nelson J, Qian L, Smith N, Vazquez-Benitez G, Weintraub E, Williams JTB, Xu S, Maro JC. Katherine Yih W, et al. Among authors: xu s. Vaccine. 2023 Jan 9;41(2):460-466. doi: 10.1016/j.vaccine.2022.11.053. Epub 2022 Nov 24. Vaccine. 2023. PMID: 36481108 Free PMC article.

2

Immunization registry-based recall for a new vaccine.

Daley MF, Steiner JF, Brayden RM, Xu S, Morrison S, Kempe A. Daley MF, et al. Among authors: xu s. Ambul Pediatr. 2002 Nov-Dec;2(6):438-43. doi: 10.1367/1539-4409(2002)002<0438:irbrfa>2.0.co;2. Ambul Pediatr. 2002. PMID: 12437389 Clinical Trial.

3

Effect of CME on primary care and OB/GYN treatment of breast masses.

Price DW, Xu S, McClure D. Price DW, et al. Among authors: xu s. J Contin Educ Health Prof. 2005 Fall;25(4):240-7. doi: 10.1002/chp.37. J Contin Educ Health Prof. 2005. PMID: 16365900

4

Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations.

Glanz JM, McClure DL, Xu S, Hambidge SJ, Lee M, Kolczak MS, Kleinman K, Mullooly JP, France EK. Glanz JM, et al. Among authors: xu s. J Clin Epidemiol. 2006 Aug;59(8):808-18. doi: 10.1016/j.jclinepi.2005.11.012. Epub 2006 Mar 15. J Clin Epidemiol. 2006. PMID: 16828674

5

Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old.

Hambidge SJ, Glanz JM, France EK, McClure D, Xu S, Yamasaki K, Jackson L, Mullooly JP, Zangwill KM, Marcy SM, Black SB, Lewis EM, Shinefield HR, Belongia E, Nordin J, Chen RT, Shay DK, Davis RL, DeStefano F; Vaccine Safety Datalink Team. Hambidge SJ, et al. Among authors: xu s. JAMA. 2006 Oct 25;296(16):1990-7. doi: 10.1001/jama.296.16.1990. JAMA. 2006. PMID: 17062862

6

Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants.

France EK, Smith-Ray R, McClure D, Hambidge S, Xu S, Yamasaki K, Shay D, Weintraub E, Fry AM, Black SB, Shinefield HR, Mullooly JP, Jackson LA. France EK, et al. Among authors: xu s. Arch Pediatr Adolesc Med. 2006 Dec;160(12):1277-83. doi: 10.1001/archpedi.160.12.1277. Arch Pediatr Adolesc Med. 2006. PMID: 17146026

7

Comparison of epidemiologic methods for active surveillance of vaccine safety.

McClure DL, Glanz JM, Xu S, Hambidge SJ, Mullooly JP, Baggs J. McClure DL, et al. Among authors: xu s. Vaccine. 2008 Jun 19;26(26):3341-5. doi: 10.1016/j.vaccine.2008.03.074. Epub 2008 May 6. Vaccine. 2008. PMID: 18462849

8

Identifying optimal risk windows for self-controlled case series studies of vaccine safety.

Xu S, Zhang L, Nelson JC, Zeng C, Mullooly J, McClure D, Glanz J. Xu S, et al. Stat Med. 2011 Mar 30;30(7):742-52. doi: 10.1002/sim.4125. Epub 2010 Nov 30. Stat Med. 2011. PMID: 21394750

9

A scan statistic for identifying optimal risk windows in vaccine safety studies using self-controlled case series design.

Xu S, Hambidge SJ, McClure DL, Daley MF, Glanz JM. Xu S, et al. Stat Med. 2013 Aug 30;32(19):3290-9. doi: 10.1002/sim.5733. Epub 2013 Jan 10. Stat Med. 2013. PMID: 23303643 Free PMC article.

10

Bias correction of risk estimates in vaccine safety studies with rare adverse events using a self-controlled case series design.

Zeng C, Newcomer SR, Glanz JM, Shoup JA, Daley MF, Hambidge SJ, Xu S. Zeng C, et al. Among authors: xu s. Am J Epidemiol. 2013 Dec 15;178(12):1750-9. doi: 10.1093/aje/kwt211. Epub 2013 Sep 27. Am J Epidemiol. 2013. PMID: 24327463

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,793 results

Search Page

Filters